Paliperidone palmitate

(Invega Sustenna)

Paliperidone palmitate

Drug updated on 8/25/2023

Dosage FormInjection (intramuscular; 39 mg/0.25 mL, 78 mg/0.5 mL, 117 mg/0.75 mL, 156 mg/mL, or 234 mg/1.5 mL)
Drug ClassAtypical antipsychotic
Ongoing and Completed StudiesClinicalTrials.gov

Indication

  • For treatment of schizophrenia in adults.
  • For treatment of schizoaffective disorder in adults as monotherapy and as an adjunct to mood stabilizers or antidepressants.